We are live on ! Find out more
RA

Rovida Advisors Portfolio holdings

AUM $116M
1-Year Est. Return 12.52%
This Fund
S&P 500
This Quarter Est. Return
-2.39%
1 Year Est. Return
-12.52%
3 Year Est. Return
+24.79%
5 Year Est. Return
+5%
10 Year Est. Return
+130.97%
AUM
$450M
AUM Growth
+$248M
Cap. Flow
+$256M
Cap. Flow %
56.96%
Top 10 Hldgs %
86.27%
Holding
18
New
8
Increased
5
Reduced
3
Closed
2

Sector Composition

Rank Sector Weight
1 Consumer Staples 22.51%
2 Healthcare 19.91%
3 Financials 18.75%
4 Materials 16.25%
5 Consumer Discretionary 15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTB icon
1
Bank of N.T. Butterfield & Son
NTB
$2.4B
$63M 14.01%
2,004,828
-1
-0% -$28
AMZN icon
2
Amazon
AMZN
$2.63T
$57.6M 12.81%
+1,536,400
New +$60.2M
SPB icon
3
Spectrum Brands
SPB
$2.05B
$55.2M 12.28%
+451,291
New +$57.6M
OEC icon
4
Orion
OEC
$426M
$50.9M 11.32%
2,700,000
+140,000
+5% +$2.67M
REV
5
DELISTED
Revlon, Inc.
REV
$46M 10.23%
1,581,400
+131,400
+9% +$4.1M
XLV icon
6
State Street Health Care Select Sector SPDR ETF
XLV
$41.3B
$33.9M 7.54%
+492,000
New +$34.2M
LLY icon
7
Eli Lilly
LLY
$1.04T
$21.8M 4.85%
+296,300
New +$22.1M
EZPW icon
8
Ezcorp Inc
EZPW
$2B
$21.3M 4.74%
2,000,000
+670,000
+50% +$7.22M
JNJ icon
9
Johnson & Johnson
JNJ
$615B
$19.4M 4.32%
+168,500
New +$19.5M
FCX icon
10
Freeport-McMoran
FCX
$93.4B
$18.8M 4.18%
+1,425,000
New +$18.2M
MRK icon
11
Merck
MRK
$315B
$18.7M 4.15%
+332,216
New +$19.4M
MDRX
12
DELISTED
Veradigm Inc. Common Stock
MDRX
$15.3M 3.41%
1,501,900
+750,000
+100% +$8.56M
GILD icon
13
Gilead Sciences
GILD
$162B
$14.3M 3.18%
+200,000
New +$14.9M
LIND icon
14
Lindblad Expeditions
LIND
$1.82B
$9.83M 2.19%
1,041,233
+6,233
+0.6% +$56.9K
CLMT icon
15
Calumet Specialty Products
CLMT
$3.85B
$3.4M 0.75%
859,520
-235,520
-22% -$961K
CWCO icon
16
Consolidated Water Co
CWCO
$470M
$225K 0.05%
20,757
-15,300
-42% -$169K
NCLH icon
17
Norwegian Cruise Line
NCLH
$8.87B
-50,000
Closed -$1.89M
TOO
18
DELISTED
Teekay Offshore Partners L.P.
TOO
-1,500,000
Closed -$9.46M

Similar funds

Rovida Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Rovida Advisors held 18 positions worth $450M, up 123% from $201M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Rovida Advisors deployed $256M of net new capital in Q4 2016, opening 8 new positions and adding to 5 existing holdings. Its largest new stake was Amazon: 1,536,400 shares worth $57.6M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Calumet Specialty Products, an estimated $961K trimmed.

  • Rovida Advisors's largest Q4 2016 buy was Amazon: 1,536,400 shares worth $57.6M.
  • Rovida Advisors added most to Veradigm Inc. Common Stock in Q4 2016, an estimated $8.56M increase.
  • Rovida Advisors's biggest Q4 2016 reduction was Calumet Specialty Products, cutting an estimated $961K.
  • Rovida Advisors fully exited Teekay Offshore Partners L.P. in Q4 2016, selling an estimated $9.46M.
  • Rovida Advisors's ten largest holdings make up 86% of its $450M portfolio in Q4 2016.
  • Rovida Advisors opened 8 new positions and closed 2 in Q4 2016.
  • Rovida Advisors's portfolio value rose 123% quarter-over-quarter to $450M.

Based on Rovida Advisors's 13F filing for Q4 2016, filed 2 Feb 2017.